Cargando…

R-Score: A New Parameter to Assess the Quality of Variants’ Calls Assessed by NGS Using Liquid Biopsies

SIMPLE SUMMARY: Circulating tumor DNA profiling by next-generation sequencing (NGS) is becoming essential for guiding targeted therapies. However, it remains challenging. Here, we show that variant allele fraction and the median of absolute values of all pairwise differences impact the agreement bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Serna-Blasco, Roberto, Sánchez-Herrero, Estela, Berrocal Renedo, María, Calabuig-Fariñas, Silvia, Molina-Vila, Miguel Ángel, Provencio, Mariano, Romero, Atocha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533561/
https://www.ncbi.nlm.nih.gov/pubmed/34681053
http://dx.doi.org/10.3390/biology10100954
_version_ 1784587343409184768
author Serna-Blasco, Roberto
Sánchez-Herrero, Estela
Berrocal Renedo, María
Calabuig-Fariñas, Silvia
Molina-Vila, Miguel Ángel
Provencio, Mariano
Romero, Atocha
author_facet Serna-Blasco, Roberto
Sánchez-Herrero, Estela
Berrocal Renedo, María
Calabuig-Fariñas, Silvia
Molina-Vila, Miguel Ángel
Provencio, Mariano
Romero, Atocha
author_sort Serna-Blasco, Roberto
collection PubMed
description SIMPLE SUMMARY: Circulating tumor DNA profiling by next-generation sequencing (NGS) is becoming essential for guiding targeted therapies. However, it remains challenging. Here, we show that variant allele fraction and the median of absolute values of all pairwise differences impact the agreement between digital PCR and NGS calls. Therefore, we propose a new parameter, named R-score, which integrates both variables, and we evaluate its usefulness for optimizing NGS variant calling. ABSTRACT: Next-generation sequencing (NGS) has enabled a deeper knowledge of the molecular landscape in non-small cell lung cancer (NSCLC), identifying a growing number of targetable molecular alterations in key genes. However, NGS profiling of liquid biopsies risk for false positive and false negative calls and parameters assessing the quality of NGS calls remains lacking. In this study, we have evaluated the positive percent agreement (PPA) between NGS and digital PCR calls when assessing EGFR mutation status using 85 plasma samples from 82 EGFR-positive NSCLC patients. According to our data, variant allele fraction (VAF) was significantly lower in discordant calls and the median of the absolute values of all pairwise differences (MAPD) was significantly higher in discordant calls (p < 0.001 in both cases). Based on these results, we propose a new parameter that integrates both variables, named R-score. Next, we sought to evaluate the PPA for EGFR mutation calls between two independent NGS platforms using a subset of 40 samples from the same cohort. Remarkably, there was a significant linear correlation between the PPA and the R-score (r = 0.97; p < 0.001). Specifically, the PPA of samples with an R-score ≤ −1.25 was 95.83%, whereas PPA falls to 81.63% in samples with R-score ≤ 0.25. In conclusion, R-score significantly correlates with PPA and can assist laboratory medicine specialists and data scientists to select reliable variants detected by NGS.
format Online
Article
Text
id pubmed-8533561
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85335612021-10-23 R-Score: A New Parameter to Assess the Quality of Variants’ Calls Assessed by NGS Using Liquid Biopsies Serna-Blasco, Roberto Sánchez-Herrero, Estela Berrocal Renedo, María Calabuig-Fariñas, Silvia Molina-Vila, Miguel Ángel Provencio, Mariano Romero, Atocha Biology (Basel) Article SIMPLE SUMMARY: Circulating tumor DNA profiling by next-generation sequencing (NGS) is becoming essential for guiding targeted therapies. However, it remains challenging. Here, we show that variant allele fraction and the median of absolute values of all pairwise differences impact the agreement between digital PCR and NGS calls. Therefore, we propose a new parameter, named R-score, which integrates both variables, and we evaluate its usefulness for optimizing NGS variant calling. ABSTRACT: Next-generation sequencing (NGS) has enabled a deeper knowledge of the molecular landscape in non-small cell lung cancer (NSCLC), identifying a growing number of targetable molecular alterations in key genes. However, NGS profiling of liquid biopsies risk for false positive and false negative calls and parameters assessing the quality of NGS calls remains lacking. In this study, we have evaluated the positive percent agreement (PPA) between NGS and digital PCR calls when assessing EGFR mutation status using 85 plasma samples from 82 EGFR-positive NSCLC patients. According to our data, variant allele fraction (VAF) was significantly lower in discordant calls and the median of the absolute values of all pairwise differences (MAPD) was significantly higher in discordant calls (p < 0.001 in both cases). Based on these results, we propose a new parameter that integrates both variables, named R-score. Next, we sought to evaluate the PPA for EGFR mutation calls between two independent NGS platforms using a subset of 40 samples from the same cohort. Remarkably, there was a significant linear correlation between the PPA and the R-score (r = 0.97; p < 0.001). Specifically, the PPA of samples with an R-score ≤ −1.25 was 95.83%, whereas PPA falls to 81.63% in samples with R-score ≤ 0.25. In conclusion, R-score significantly correlates with PPA and can assist laboratory medicine specialists and data scientists to select reliable variants detected by NGS. MDPI 2021-09-24 /pmc/articles/PMC8533561/ /pubmed/34681053 http://dx.doi.org/10.3390/biology10100954 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Serna-Blasco, Roberto
Sánchez-Herrero, Estela
Berrocal Renedo, María
Calabuig-Fariñas, Silvia
Molina-Vila, Miguel Ángel
Provencio, Mariano
Romero, Atocha
R-Score: A New Parameter to Assess the Quality of Variants’ Calls Assessed by NGS Using Liquid Biopsies
title R-Score: A New Parameter to Assess the Quality of Variants’ Calls Assessed by NGS Using Liquid Biopsies
title_full R-Score: A New Parameter to Assess the Quality of Variants’ Calls Assessed by NGS Using Liquid Biopsies
title_fullStr R-Score: A New Parameter to Assess the Quality of Variants’ Calls Assessed by NGS Using Liquid Biopsies
title_full_unstemmed R-Score: A New Parameter to Assess the Quality of Variants’ Calls Assessed by NGS Using Liquid Biopsies
title_short R-Score: A New Parameter to Assess the Quality of Variants’ Calls Assessed by NGS Using Liquid Biopsies
title_sort r-score: a new parameter to assess the quality of variants’ calls assessed by ngs using liquid biopsies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533561/
https://www.ncbi.nlm.nih.gov/pubmed/34681053
http://dx.doi.org/10.3390/biology10100954
work_keys_str_mv AT sernablascoroberto rscoreanewparametertoassessthequalityofvariantscallsassessedbyngsusingliquidbiopsies
AT sanchezherreroestela rscoreanewparametertoassessthequalityofvariantscallsassessedbyngsusingliquidbiopsies
AT berrocalrenedomaria rscoreanewparametertoassessthequalityofvariantscallsassessedbyngsusingliquidbiopsies
AT calabuigfarinassilvia rscoreanewparametertoassessthequalityofvariantscallsassessedbyngsusingliquidbiopsies
AT molinavilamiguelangel rscoreanewparametertoassessthequalityofvariantscallsassessedbyngsusingliquidbiopsies
AT provenciomariano rscoreanewparametertoassessthequalityofvariantscallsassessedbyngsusingliquidbiopsies
AT romeroatocha rscoreanewparametertoassessthequalityofvariantscallsassessedbyngsusingliquidbiopsies